Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice

Teratology

Volumn 55, Issue 5, 1997, Pages 306-313

  Hall, J L ^a   Harris, M J ^a   Juriloff, D M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TERATOGENIC AGENT; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMBRYO; EXENCEPHALY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MULTIFACTORIAL INHERITANCE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; RISK; STRAIN DIFFERENCE; TERATOGENESIS; XENOBIOTIC METABOLISM;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BRAIN; DISEASE SUSCEPTIBILITY; FEMALE; FETAL DEATH; MICE; MICE, INBRED STRAINS; PREGNANCY; TERATOGENS; VALPROIC ACID;

ANIMALIA;

EID: 0030765760     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199705)55:5<306::AID-TERA2>3.0.CO;2-X     Document Type: Article

References (43)

1. Biddle, F.G. (1975) Teratogenesis of acetazolamide in the CBA/J and SWV strains of mice. I. Teratology. Teratology, 11:31-36.
2. Biddle, F.G. (1981) The role of genetic studies in developmental toxicology. In: Developmental Toxicology. C.A. Kimmel and J. Buelke-Sam, eds. Raven Press, New York, pp. 55-82.
3. Biddle, F.G., and F.C. Fraser (1976) Genetics of cortisone-induced cleft palate in the mouse: Embryonic and maternal effects. Genetics, 84:743-754.
4. Bronson, F.H., C.P. Dagg, and G.D. Snell (1966) Reproduction. In: Biology of the Laboratory Mouse. E.L. Green, ed. Dover, New York, pp. 194-195.
5. Cassells, B., P. Wainwright, and K. Blom (1987) Heredity and alcohol-induced brain anomalies: Effects of alcohol on anomalous prenatal development of the corpus callosum and anterior commissure in BALB/c and C57BL/6 mice. Exp. Neurol., 95:587-604.
6. Dagg, C.P. (1966) Teratogenesis. In: Biology of the Laboratory Mouse. E.L. Green, ed. Dover, New York, pp. 309-328.
7. Dagg, C.P., G. Schlager, and A. Doerr (1966) Polygenic control of the teratogenicity of 5-fluorouracil in mice. Genetics, 53:1101-1117.
8. Diwan, B.A. (1974) Strain-dependent teratogenic effects of 1-ethyl-1-nitrosourea in inbred strains of mice. Cancer Res., 34:151-157.
9. Eales, B.A., M. Nahas, and F.G. Biddle (1996) Directional dominance and a developmental model for the expression of the Tda testis-determining autosomal trait of the mouse. Genome, 39:520-527.
10. Ehlers, K., H. Sturje, H.J. Merker, and H. Nau (1992) Valproic acid-induced spina bifida: A mouse model. Teratology, 45:145-154.
11. Elmazar, M.M., R. Thiel, and H. Nau (1992) Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice. Fundam. Appl. Toxicol., 18:389-394.
12. Falconer, D.S. (1981) Threshold characters. In: Introduction to Quantitative Genetics, 2nd ed. Longman, New York, pp. 271-280.
13. Finnell, R.H. (1991) Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects (review). Pharmacol. Toxicol., 69:223-227.
14. Finnell, R.H., S.P. Moon, L.C. Abbott, J.A. Golden, and G.F. Chernoff (1986) Strain differences in heat-induced neural tube defects in mice. Teratology, 33:247-252.
15. Finnell, R.H., G.D. Bennett, S.B. Karras, and V.K. Mohl (1988) Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology, 38:313-320.
16. Finney, D.J. (1971) Probit Analysis. New York: Cambridge University Press.
17. Fraser, F.C. (1977) Interactions and multiple causes. In: Handbook of Teratology. J.G. Wilson and F.C. Fraser, eds. Plenum Press, New York, Vol. 1, pp. 445-463.
18. Fraser, F.C. (1980) The William Allan Memorial Award address: Evolution of a palatable multifactorial threshold model. Am. J. Hum. Genet., 32:796-813.
19. Gunn, T.M., D.M. Juriloff, and M.J. Harris (1992) Further genetic studies of the cause of exencephaly in SELH mice. Teratology, 45:679-686.
20. Gunn, T.M., D.M. Juriloff, and M.J. Harris (1995) Genetically determined absence of an initiation site of cranial neural tube closure is causally related to exencephaly in SELH/Bc mouse embryos. Teratology, 52:101-108.
21. Ingalls, T.H., F.R. Avis, F.J. Curley, and H.M. Temin (1953) Genetic determinants of hypoxia-induced congenital anomalies. J. Hered., 44:185-194.
22. Juriloff, D.M. (1994) Discussion. In: Neural Tube Defects. G. Bock and J. Marsh, eds. John Wiley & Sons, Chichester, pp. 134-143.
23. Juriloff, D.M., K.B. Macdonald, and M.J. Harris (1989) Genetic analysis of the cause of exencephaly in the SELH/Bc mouse stock. Teratology, 40:395-405.
24. Juriloff, D.M., M.J. Harris, C. Tom, and K.B. Macdonald (1991) Normal mouse strains differ in the site of initiation of closure of the cranial neural tube. Teratology, 44:225-233.
25. Kao, J., N.A. Brown, B. Schmid, E.H. Goulding, and S. Fabro (1981) Teratogenicity of valproic acid: In vivo and in vitro investigations. Teratogen. Carcinogen. Mutagen., 1:367-382.
26. Lammer, E.J., L.E. Sever, and G.P. Oakley, Jr. (1987) Teratogen update: Valproic acid (review). Teratology, 35:465-473.
27. Lindhout, D., and H. Meinardi (1984) Spina bifida and in-utero exposure to valproate (letter). Lancet, 2:396.
28. Lindhout, D., J.G. Omtzigt, and M.C. Cornel (1992) Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology, 42:111-118.
29. Macdonald, K.B., D.M. Juriloff, and M.J. Harris (1989) Developmental study of neural tube closure in a mouse stock with a high incidence of exencephaly. Teratology, 39:195-213.
30. Matsuda, M. (1990) Comparison of the incidence of 5-azacytidine-induced exencephaly between MT/HokIdr and Slc:ICR mice. Teratology, 41:147-154.
31. Mosteller, F., and C. Youtz (1961) Tables of the Freeman-Tukey transformations for the binomial and Poisson distributions. Biometrika, 48:433-440.
32. Naruse, I., M.D. Collins, and W.J. Scott, Jr. (1988) Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. Teratology, 38:87-96.
33. Nau, H. (1994) Valproic acid-induced neural tube defects (review). Ciba Found. Symp., 181:144-156.
34. Nau, H., R. Zierer, H. Spielmann, D. Neubert, and C. Gansau (1981) A new model for embryotoxicity testing: Teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci., 29:2803-2814.
35. Paulson, R.B., M.E. Sucheston, T.G. Hayes, and G.W. Paulson (1985) Teratogenic effects of valproate in the CD-1 mouse fetus. Arch. Neurol., 42:980-983.
36. Robert, E., and P. Guibaud (1982) Maternal valproic acid and congenital neural tube defects (letter). Lancet, 2:937.
37. Seller, M.J., and K.J. Perkins-Cole (1987) Hyperthermia and neural tube defects of the curly-tail mouse. J. Craniofac. Genet. Dev. Biol., 7:321-330.
38. Smithberg, M. (1967) Teratogenesis in inbred strains of mice. In: Advances in Teratology. D.H.M. Woollam, ed. Academic Press, New York, Vol. 2, pp. 257-288.
39. Sokal, R.R., and F.J. Rohlf (1969) Biometry. San Francisco: W.H. Freeman.
40. Tom, C., D.M. Juriloff, and M.J. Harris (1991) Studies of the effect of retinoic acid on anterior neural tube closure in mice genetically liable to exencephaly. Teratology, 43:27-40.
41. Turner, S., M.E. Sucheston, R.M. De Philip, and R.B. Paulson (1990) Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate. Teratology, 41:421-442.
42. Vekemans, M., and F.C. Fraser (1979) Stage of palate closure as one indication of "liability" to cleft palate. Am. J. Med. Genet., 4:95-102.
43. Zar, J.H. (1984) Multiple comparisons. In: Biostatistical Analysis, 2nd ed. Prentice-Hall, Englewood Cliffs, NJ, pp. 185-205.